Xenon-inhibition of the MscL mechano-sensitive channel and the CopB copper ATPase under different conditions suggests direct effects on these proteins

Evgeny Petrov; Gopalakrishnan Menon; Paul R. Rohde; Andrew R. Battle; Boris Martinac; Marc Solioz

doi:10.1371/journal.pone.0198110

Abstract

Xenon is frequently used as a general anesthetic in humans, but the mechanism remains an issue of debate. While for some membrane proteins, a direct interaction of xenon with the protein has been shown to be the inhibitory mechanism, other membrane protein functions could be affected by changes of membrane properties due to partitioning of the gas into the lipid bilayer. Here, the effect of xenon on a mechanosensitive ion channel and a copper ion-translocating ATPase was compared under different conditions. Xenon inhibited spontaneous gating of the Escherichia coli mechano-sensitive mutant channel MscL-G22E, as shown by patch-clamp recording techniques. Under high hydrostatic pressure, MscL-inhibition was reversed. Similarly, the activity of the Enterococcus hirae CopB copper ATPase, reconstituted into proteoliposomes, was inhibited by xenon. However, the CopB ATPase activity was also inhibited by xenon when CopB was in a solubilized state. These findings suggest that xenon acts by directly interacting with these proteins, rather than via indirect effects by altering membrane properties. Also, inhibition of copper transport may be a novel effect of xenon that contributes to anesthesia.

Citation: Petrov E, Menon G, Rohde PR, Battle AR, Martinac B, Solioz M (2018) Xenon-inhibition of the MscL mechano-sensitive channel and the CopB copper ATPase under different conditions suggests direct effects on these proteins. PLoS ONE 13(6): e0198110. https://doi.org/10.1371/journal.pone.0198110

Editor: Anthony M. George, University of Technology Sydney, AUSTRALIA

Received: August 11, 2017; Accepted: May 14, 2018; Published: June 4, 2018

Copyright: © 2018 Petrov et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the paper and its Supporting Information files.

Funding: All the funding or sources of support received during this specific study have been declared. They were the following: Russian Federation Ministry of Education and Science grant no. 14.Z50.31.0011 to MS; Australian National Health and Medical Research Council grant no. 00 to BM; and Carlsbergfondet, Denmark grant no. CF14-0613 to BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

There has been substantial interest in using noble gases as 'ideal' general anesthetics for more than half a century [1,2]. Noble gases are also useful as a tool in biophysical studies of properties of biological membranes and their protein constituents. Being chemically inert, noble gases have preferential affinity for the hydrophobic environment, which provides an opportunity to directly manipulate the functioning of phospholipid membranes [3–5]. The effectiveness of volatile anesthetics follows the Meyer-Overton rule [6,7], which states that a greater solubility in olive oil is correlated to a greater anesthetic potency [8]. This describes, but does not explain the anesthetic effects. It has remained a matter of debate whether volatile anesthetics solely work by nonspecific effects on the membrane, or also via a specific interaction with membrane receptors, pumps, or channels.

As xenon is highly soluble in the lipid bilayer, its presence will affect the properties of the bilayer. In particular, when dissolved in phospholipid bilayers, xenon influences parameters such as membrane thickness [5], lateral pressure profile [9], melting point and phase transition temperature [4]. By altering membrane properties, xenon may affect the function of integral membrane proteins indirectly. On the other hand, it was shown that xenon also binds to hydrophobic sites within proteins. This was demonstrated for both, soluble proteins and integral membrane proteins. X-ray diffraction studies of a number of enzymes have revealed that xenon binds to hydrophobic cavities in proteins through weak but specific dipole-induced dipole interactions [10]. In the membrane-embedded cytochrome ba₃ oxidase of Thermus thermophilus, xenon atoms were shown to line the hydrophobic channel that provides access of O₂ to the a₃-Cu_B center [11].

The GABAergic system has been considered as a prime target for mediating the anesthetic effects of xenon [12–14]. More recently, xenon was shown to competitively inhibit the N-methyl-D-aspartate receptor by binding to the glycine binding site [15][16]. Xenon also acts on other channels like TREK-1 or adenosine triphosphate-sensitive potassium (K_ATP) channels and several of these inhibitory effects contribute to the neuroprotection against traumatic brain injury by xenon [17–19]. Detailed mapping of the xenon binding sites by X-ray crystallography was conducted on the ligand-gated ion channel GLIC of Gloebacter violaceus [20]. GLIC is a member of the pLGIC family, which also includes serotonin, n-acetylcholine, glycine, and GABA receptors. Xenon binding to three distinct regions in the trans-membrane domain of GLIC was observed: to an intra-subunit cavity, at the interface between adjacent subunits, and in the pore, which was effectively sealed by the bound xenon. Clearly, intra-protein binding of xenon is a pharmacologically relevant mechanism, although this does not rule out the possibility that xenon directly affects membrane properties, which can in turn affect the function of integral membrane proteins within.

To compare the effects of xenon on a protein under different membrane conditions, we measured xenon-inhibition of the mechano-sensitive channel of large conductance (MscL) of Escherichia coli at ambient and high pressure and the copper transporting ATPase CopB of Enterococcus hirae in solution and in a membrane-bound state. MscL is a robust mechano-sensitive channel for multiple ions (non-selective) and its gating activity can be modulated by physical [21–23] or chemical [24–28] means. MscL of E. coli is homologous to MscL of Mycobacterium tuberculosis, for which an X-ray structure is available [29]. The crystal structure shows that the channel is a homo-pentamer. Each monomer contains two transmembrane helices and has the N- and C-terminal domains located on the cytoplasmic side of the membrane. The first of the two transmembrane domains that exist per subunit contain a cluster of hydrophobic residues which form a ‘hydrophobic lock’ within the pentameric channel pore. Membrane thickness and hydrophobic mismatch between the MscL protein and the membrane have a direct impact on the functional state of wild-type MscL [21,23,25,26]. In this study, we used a G22E mutant of E. coli MscL (MscL-G22E) to evaluate the effects of xenon on the channels gating activity. The G22E mutation induces the channel to spontaneously open with a gating function without a tension being deliberately applied to the membrane. It was found that xenon completely inhibits the spontaneous activity of MscL-G22E. This effect could be reversed by applying increased hydrostatic pressure to membrane patches containing these channels, suggesting direct effects of xenon on the protein.

To obtain further evidence for direct effects of xenon on a membrane protein, we used the CopB copper ATPase of E. hirae [30]. The copper pumping activity by CopB is directly linked to ATP hydrolysis: if no copper ions are available for transport, no ATP hydrolysis takes place [31]. This allows the recording of CopB activity not only in a membrane environment, but also in a solubilized state in the absence of phospholipids by monitoring ATP hydrolysis. Xe inhibited CopB in both, the membrane-bound and the solubilized state. These observations suggest that xenon primarily exerts its inhibitory effect directly on the membrane proteins studies here, rather than via changes of membrane properties.

Materials and methods

Cell-free expression construct and MscL-G22E

Wild-type MscL was PCR-amplified from the MscL pGEX1.1 expression vector [32], employing primers 5'-gacctgcagctggttccgcgtgga and 5'-attaagctttcaggcgcttgtta, followed by subcloning into pQE-31 (Qiagen, Germantown, MD), cut with PstI and HindIII. In the resulting clone, MscL 2.1, MscL is endowed with a thrombin-cleavable N-terminal histidine tag, resulting in the following amino acid sequence before MscL’s Met1: MRGSHHHHHHTDPHASSVPRVDLQLVPRGSLEHRENN. The N-terminus after thrombin cleavage is underlined. For cell-free expression using E. coli extracts, the coding sequence was subcloned by PCR with primers 5’-AAATTTCATATGAGAGGATCTCACCAT and 5’-TAGGTAAAGCTTTCAGGCGCTTGT into the NdeI and HindIII sites of pET-17b (Novagen), resulting in clone MscL 3.1. The MscL-G22E mutation was obtained by site-directed mutagenesis of clone MscL 2.1 with the QuikChange II kit (Stratagene, La Jolla, CA), using primers 5'-gtggatttggcggtggaggtcattatcggtgcgg and 5'-ccgcaccgataatgacctccaccgccaaatccac.

MscL-G22E was produced using a cell-free expression system essentially as described previously [33]. Briefly, the inner reaction was scaled to 2.52 mL with 30 mL outer buffer, and incubated for 13 h with longitudinal shaking at 200 min^-1 and a ¾-inch stroke at 37 °C. The inner reactions were centrifuged for 20 min at 12,000 x g at 4 °C. An 8 μL aliquot of each supernatant was run on a 12% SDS-polyacrylamide gel for analysis. MscL-G22E was solubilized with 1% n-dodecyl-β-D-maltoside (Affymetrix, Santa Clara, CA) and combined with 450 μL of PBS-washed Talon metal affinity resin (Clontech, Mountain View, CA) to allow binding to the 6His-MscL-G22E for 2 h. The resin was then pelleted and washed with 1 mM n-dodecyl-β-D-maltoside in PBS pH 7.5, and re-suspended to a final volume of 100 μL in the same buffer. MscL-G22E was released from the affinity resin by cleavage with 0.58 U of thrombin (Biopur, Bubendorf, Switzerland) at 4 °C for three days. MscL released from the column was analyzed by SDS gel electrophoresis (Figure A in S1 File).

Liposome reconstitution of MscL-G22E

Purified MscL-G22E was reconstituted into soybean phospholipid liposomes using a dehydration/rehydration (D/R) technique, modified from Häse et al. [32] and Delcour et al. [34]: 20 mg of dry soybean phospholipids were placed in a glass centrifuge tube and dissolved in 1–2 mL of chloroform. The chloroform was evaporated with a stream of nitrogen with constant rotating of the tube to form a uniform lipid layer without lumps, followed by 20 min of drying with a stronger N₂ stream. The dried soybean phospholipids were resuspended in 2 mL of D/R buffer (200 mM KCl, 5mM K-HEPES, pH 7.2) using a small brush, followed by sonication for 10 min in a bath sonicator to obtain a transparent, opalescent suspension. MscL-G22E was mixed with 200 μL of lipid suspension to achieve a protein/lipid mass ratio of 1:1000. The mixture was diluted with D/R buffer to 3 mL and mixed on a platform rocker for 1 h, then 20–30 mg of Biobeads (BioRad, Hercules, CA) were added for a further 3 h. The beads were allowed to settle, and the supernatant was centrifuged at 440,000 x g for 30 min. The pellet was resuspended in 40 μL D/R buffer and 20 μL aliquots were put as spots on microscope cover glasses and dehydrated overnight in a desiccator. The spots were then rehydrated by placing 15–20 μL of D/R buffer on each spot and left for 24 h at 4 °C. A small amount (1–2 μL) of proteoliposomes was placed in the recording chamber containing the recording solution. Thin-walled bubbles started to appear on the sides of lumps of lipid after 10–20 min and were used for patch-clamping.

Patch clamp and “flying-patch” electrophysiology of MscL-G22E

Spontaneous activity of MscL-G22E was recorded using the patch clamp technique in voltage clamp mode [35]. For measurements at increased hydrostatic pressure, the “flying-patch” methodology previously described was used; it is chiefly a mechanical device that allows easy transfer a membrane patch to high-pressure conditions [36,37]. If MscL-G22E was active for at least 5 min, recording and data analysis were conducted as previously described [36,37]. All recordings were repeated 3 to 7 times.

Measurements with xenon

To saturate buffer with xenon, a 500-ml bottle containing buffer was attached to a cyclic saturator (Figure B in S1 File) and xenon was pumped through the solution at 4 °C overnight. Xenon-saturated solutions were stored in 5 mL aliquots in sealed syringes at -80 °C. The effectiveness of Xe-saturation of solutions was measured by mass spectrometry with a DSQ II Dual Stage Quadrupole GC/MS spectrometer, using the ¹³²Xe isotope and calibration with gas samples containing 5%, 15% and 100% of xenon in air at atmospheric pressure. Based on the calibration curves (Figure C in S1 File), the xenon-saturated buffers contained ~6% (v/v) Xe. To determine the effects of xenon on protein activities, xenon-saturated buffer was added to patch clamp recordings or was used as assay buffer to measure ATPase activities. Since xenon diffuses only very slowly out of solution, the assays could be performed without any further precautions.

CopB ATPase purification

The E. hirae mutant Yl that lacks the CopY repressor and thus overexpresses the cop operon about 50-fold was used for CopB purification [38]. Y1 cells were grown in semi anaerobic conditions in two liters of N-media (60 mM Na₂HPO₄, 1% peptone, 0.5% yeast extract, 1% glucose, pH 7.8–8.0) at 37 °C to an OD at 600 nm of 1 to 1.5 and centrifuged at room temperature for 12 min at 8000 x g. The cells were washed in 1/10 volume of 2 mM MgSO₄ by centrifuging at room temperature for 12 min at 8000 x g. The wet weight of the cells was determined and cells were resuspended in 6 mL/g wet cells of 250 mM K₂SO₄, 2 mM MgSO₄, 50 mM K-HEPES, pH 7.2. Lysozyme (4 mg/g wet cells) was added and the suspension incubated in a shaking water bath at 37 °C for 45 min. Then, 200 μg/g of wet cells of DNase 1 was added and incubation continued for 15 min. The cells were centrifuged for 12 min at 23,000 x g and 4 °C and resuspended in 2 ml/g wet cells of 20 mM Tris-SO₄ pH 7.5, 5 mM MgSO₄, 25 mM Na₂SO₄, 25 mM K₂SO₄, 1 mM β-mercaptoethanol, 1 μM CuSO₄, 20% (v/v) glycerol) and 1/100 volume of protease inhibitor cocktail (Table A in S1 File) and the pellet re-suspended using a Potter-Elvehjem homogenizer at 1000 rpm. Cells were then lysed by passing the suspension twice through a French press at 20 MPa. Cells and membranes were collected by centrifugation for 60 min at 90000 x g at 4 °C. The membrane pellet was resuspended in 0.66 mL of buffer G per g wet of cells and frozen at -20 °C. The membrane protein concentration was determined with the Bradford assay [39], using bovine serum albumin as the standard. Frozen membrane suspensions were stable for 3 months.

For CopB extraction, frozen membrane suspensions were thawed, 1/200 volume of protease inhibitor cocktail (Table A in S1 File) and 1 g of dodecyl-β-D-maltoside were added and the suspension was stirred on ice for 1 h. Extracted membranes were removed by centrifugation for 45 min at 90,000 x g and 4 °C. All further steps were conducted at 4 °C. The supernatant was supplemented with 10 mM imidazole-SO₄ pH 7.5 and loaded onto a Ni-NTA-column, pre-equilibrated with JD-buffer [20 mM Tris-SO₄ pH 7.5, 5 mM MgSO₄, 1 mM β-mercaptoethanol, 1 μM CuSO₄, 20% glycerol, 0.05% dodecyl-β-D-maltoside (DM)]. The column was washed with JD-buffer containing 10 mM imidazole-SO₄ pH 7.5, followed by JD-buffer containing 50 mM imidazole-SO₄ pH 7.5. CopB was eluted with JD-buffer containing 200 mM imidazole-SO₄ pH 7.5. The fractions were analyzed by 10% SDS-PAGE [40] and protein bands were visualized by staining with colloidal Coomassie blue (Figure D in S1 File). The fractions containing CopB were dialyzed against 250 ml of buffer A (20 mM TrisSO₄, pH 7.5) containing 0.05% DM for 2.5 h, followed by freezing at -80 °C.

Reconstitution of CopB

To reconstitute CopB into lipid vesicles, 10 mg of soybean phospholipids dissolved in ether were dried with a stream of N₂, followed high vacuum-drying for 10 min. The dried lipids were suspended in 800 μl of buffer A containing 20 mg of octyl-β-D-glucoside. The clear lipid micellar solution was equilibrated on ice for at least 10 min. All further steps were carried out at 4 °C. To the lipid solution, 200 μg of purified CopB were added, immediately followed by dialysis against 100 ml of buffer A for 2.5 h and buffer A containing 1 mM DTT for 14 h.

ATPase assays

ATPase activity of purified CopB as well as reconstituted CopB was measured by determining the release of Pi by the method of Lanzetta [41]. The 1 ml reaction mixtures for the solubilized CopB consisted of air-saturated or xenon-saturated 50 mM Na-MES, pH 6.5, 0.1% DM, 2.5 mM DTT, 5 mM MgSO₄, 1 μM CuSO₄, 1 mg/mL soybean phospholipids, and 3.75 μg of CopB. The reaction was conducted at 37 °C and started by the addition of 1 mM of Na-ATP pH 7. At 0, 5, 10, 15, and 20 min, 100 μL aliquots were removed and Pi determined as described [41]. The ATPase activity of reconstituted vesicles was determined similarly, except that the 1 ml reactions consisted of vesicles containing 7.15 μg of CopB, 50 mM Na-MES, pH 6.5, 2.5 mM DTT, 5 mM MgSO₄, 1 μM CuSO₄ and 20% (v/v) glycerol. Specific activities were calculated from the slopes of linear regressions (n = 3).

Results

Effect of xenon on MscL-G22E

The choice to utilize the gain-of-function mutant MscL-G22E instead of the wild-type MscL was based on the observation that MscL-G22E is spontaneously active in non-stretched membranes while retaining its mechanosensitivity, resulting in a greater open probability [42]. To exclude side-effects of mechanical disturbance due to increased levels of liquid in the recording chamber and shaking of the membrane patch, control recordings with xenon-free solution were performed. As seen in Fig 1A, channel activity remained relatively constant over several min. Addition of 0.5 ml of Xe-free recording bath solution did not fundamentally change the gating activity of the channels. After addition of 0.5 mL of Xe-saturated bath solution to the recording chamber, MscL-G22E became inhibited within 5 ± 2 min (n = 7) (Fig 1B). This is seen as both a significant decrease in open probability of an ensemble of two spontaneously active channels (O1, O2) and by suppression of flickering activity.

Download:

Fig 1. Effect of xenon on MscL-G22E spontaneous activity.

A. The current induced by MscL-G22E was recorded at a potential of -30 V in Xe-free buffer. At the arrow, 1/3 volume of xenon-free (Xe-) recording solution was added. B. As in A, but at the arrow, xenon-saturated (Xe+) recording solution was added. The ordinates indicate the currents corresponding to the closed state (c) and open states (O₁, O₂) of at least two spontaneously active channels.

https://doi.org/10.1371/journal.pone.0198110.g001

We also observed that the fine-structure of gating by MscL-G22E was affected by the presence of xenon. To visualize these subtle changes in sub-states of the channel, it was necessary to obtain patches containing only one or two channels. Under these conditions, it became apparent that in addition to the open and closed states, there are intermediate open states S1, S2, S3 and S4 (Fig 2). Xenon abolished all open states of MscL-G22E and reduced the activity of the channel to a very low flickering activity near the closed state.

Download:

Fig 2. Effect of xenon on MscL-G22E activity and sub-state distribution.

A. The current induced by a single MscL-G22E channel was recorded at a potential of -30 V in Xe-free buffer. At the arrow, 1/3 recording chamber volume of xenon-saturated (Xe) recording solution was added. B. Frequency distribution of conductance events due to open states (O), open sub-states (S1, S2, S3, S4) and closed states (C) in the absence of xenon. C. As in B, but in the presence of xenon.

https://doi.org/10.1371/journal.pone.0198110.g002

While the inhibition of the MscL-G22E channel by xenon is clearly apparent, it remains unclear if this is due to changes of the membrane properties or interaction of xenon with hydrophobic domains or pockets of the protein. To address this question, we examined the effect of xenon on the MscL-G22E channel under increased hydrostatic pressure, which has previously been shown to increase the open-probability of this channel [37]. Fig 3 shows that upon xenon exposure, MscL-G22E channel activity was reduced to 39 ± 7% (p < 0.0001). A step-wise increase in hydrostatic pressure reactivated the channels, reaching maximal recovery at 80 MPa (81 ± 7%, p = 0.01, Fig 3B). Higher hydrostatic pressure did not lead to significantly higher recovery of activity. Higher hydrostatic pressure, which also results in an increased xenon partial pressure, p_Xe, leads to additional thickening of the membrane [4]. If xenon would act via changes of membrane properties, elevating the hydrostatic pressure would be expected to induce channel closing, rather than the opening observed here. How pressure reactivates the xenon-inhibited channel remains speculative. It has been proposed that under pressure, water molecules around the hydrophobic gate of MscL-G22E induce hydration of the hydrophobic lock, thus increasing the opening probability of the channel [37]. This could lead to a reversal or overriding of xenon inhibition. Whatever the mechanism of high-pressure reversal of xenon inhibition is, it supports a direct action of xenon on MscL-G22E, rather than indirect effects via the membrane as the primary inhibitory mechanism.

Download:

Fig 3. Reactivation of xenon-inhibited MscL-G22E by hydrostatic pressure.

A. Patch-clamp recording with a membrane patch with an ensemble of >10 channels. Voltage and xenon applications are marked with arrows. The hydrostatic pressure was increased stepwise as indicated by the abscissa. B. Quantitative evaluation of the effects of xenon and hydrostatic pressure on MscL-G22E spontaneous activity. The data were collected from recordings like that shown in A. The error bars indicate the standard error; the number of evaluated recordings, n, is indicated in the bars. The asterisk indicates a significant difference of p ≤ 0.01.

https://doi.org/10.1371/journal.pone.0198110.g003

To strengthen the concept that xenon inhibition can results from direct interaction of xenon with the protein, rather than the membrane, we also assessed the effects of xenon on the CopB copper ATPase. The activity of this enzyme can be measured in solution as well as in the membrane bound state.

Effects of xenon on solubilized CopB

The ATPase activity of the CopB copper ATPase is tightly linked to copper transport, and thus serves as a measure of transport activity that can effectively be determined on the solubilized enzyme as well as on the enzyme reconstituted into membrane vesicles [31]. Since CopB naturally possesses a very histidine-rich N-terminal domain, it can be purified by Ni-NTA affinity chromatography without a need to modify the protein [43]. It could thus be purified from its native host as a protein which is at least 90% pure (Figure D in S1 File).

Solubilized CopB will have a comparatively small annulus of detergent surrounding the hydrophobic domain, but not the large hydrophilic portion of the protein harboring the ATP-binding and -hydrolyzing domains. Xenon-effects observed on lipid bilayers are thus unlikely to be mimicked by the small detergent annulus. When the activity of solubilized, purified CopB was measured in the absence of membrane lipids, it amounted to 976 ± 215 nmol min^-1 mg^-1 (Fig 4A, Table 1). Xenon inhibited this activity by 85%. Since no membrane was present in this experiment, the observed inhibition suggests that xenon affected the enzyme by directly targeting the protein.

Download:

Fig 4. ATPase activity of CopB was measured either without (○) or with (●) xenon in the buffer.

A. Solubilized CopB in the presence of 0.1% dodecylmaltoside. B. Solubilized CopB in the presence of 0.1% dodecylmaltoside and 10 μg/ml of soybean phospholipids. C. Reconstituted CopB in proteoliposomes. Each data point represents the release of Pi by 0.337 μg (A, B) or 0.715 μg (C) of CopB. Other details of the measurements were conducted as detailed under Material and methods. The error bars indicate the standard deviation of three independent experiments (n = 3).

https://doi.org/10.1371/journal.pone.0198110.g004

Download:

Table 1. Specific activity and xenon-inhibition of different CopB preparations.

https://doi.org/10.1371/journal.pone.0198110.t001

The addition of phospholipids to solubilized CopB will result in a mixed detergent-phospholipid annulus covering the hydrophobic domain of the protein. The basal activity of CopB under these conditions was 1046 ± 121 nmol min^-1 mg^-1 and thus not significantly different from that in the absence of phospholipids (Fig 4B, Table 1). In the presence of phospholipids, xenon inhibited CopB somewhat less, namely 75%, versus 85% in the absence of phospholipids (p < 0.001). However, if xenon were to inhibit CopB via altered phospholipid properties, higher rather than lower inhibition of CopB would be expected in the presence of phospholipids, Overall, the xenon-inhibition of CopB not integrated into a lipid bilayer suggests direct xenon-protein interaction.

Effects of xenon on reconstituted CopB

Purified CopB reconstituted into proteoliposomes by the method described here resulted in a relatively homogeneous population of unilamellar vesicles of 50 to 100 nm diameter (Figure E in S1 File). Reconstituted CopB exhibited an ATPase activity of 541 ± 81 nmol min^-1 mg^-1 (Fig 4C and Table 1). The lower activity of this preparation compared to soluble CopB is due to the random orientation of CopB in the membrane: only molecules with the cytoplasmic, ATP-binding domain, facing outside of the vesicles can be activated by externally added ATP. The activity of membrane-bound CopB was reduced to approximately 62% by xenon.

Clearly, the liposome membrane reduced xenon-inhibition of reconstituted CopB. However, the fact that solubilized CopB is more strongly inhibited by xenon than reconstituted CopB suggests that the membrane exerts a stabilizing effect on CopB and partly suppresses xenon inhibition. If membrane effects would inhibit CopB, more extensively, stronger inhibition of reconstituted CopB by xenon should have been observed. Thus, the reduced xenon-inhibition of reconstituted CopB corroborates a mechanism of xenon inhibition by direct protein interaction. Inhibition of an ion-motive ATPase by xenon has not previously been demonstrated and could have far-reaching implications in terms of general anesthesia.

Discussion

Mechanosensitive channels act as membrane-embedded mechano-electrical switches by opening an ion-conducting pore in response to lipid bilayer deformations. This process is a key to physiological responses of living organisms to mechanical stimuli, such as in touch, hearing, or osmoregulation. The osmo-regulatory protein MscL of E. coli changes its diameter from 50 Å to 70 Å when transitioning from the fully closed to the fully open state [44]. This nearly two-fold increase of the area occupied by MscL in the membrane explains why MscL readily responds to membrane lateral pressure and is thus a mechano-sensitive channel. In this study, we show for the first time that MscL-G22E, a spontaneously active mutant of MscL, is inhibited by xenon. Xenon inhibition of a membrane protein can come about by two fundamentally different mechanisms: by direct interaction of xenon with the protein, or by changes of the membrane properties as a consequence of the partitioning of xenon into the membrane.

Xenon readily diffuses into the hydrophobic region of phospholipid bilayers where it forms clathrates. Modelling studies have shown that Xe atoms are mostly located between the leaflets of the bilayer [4,5]. Xe binding to the membrane is accompanied by thickening of the membrane and a shift in the phase transition temperature [3][45]. Hydrophobic interactions are crucial for mechano-sensitive channel gating [23] and changes in membrane properties, such as the phase transition temperature, viscosity or thickness could well be the explanation of the xenon-inhibition of MscL-G22E function. In a reconstituted system where the lipid to protein ratio is typically in excess of 50 and membrane structural proteins are absent, no lateral membrane pressure can build up, even in the presence of xenon. But xenon partitioning into the membrane leads to membrane thickening, which in principle could inhibit MscL by hydrophobic mismatch between the bilayer and the channel protein [23]. Increased hydrostatic pressure enhances membrane thickening and would thus be expected to result in stronger inhibition of the channel protein. However, the opposite was observed: increased hydrostatic pressure relived inhibition of MscL-G22E by xenon, which supports a model of xenon-inhibition of MscL-G22E by interaction with the protein. Clearly, considerable additional work will be required to elucidate such a mechanism, but it will be important to investigate along these lines.

The activity of the CopB copper-pumping ATPase can be assessed both in the membrane-bound and in the solubilized state. The pumping of ions by CopB is directly coupled to ATP hydrolysis: if pumping is inhibited or the ions to be pumped are absent, no ATP hydrolysis takes place [46]. Since xenon inhibits the ATPase activity of CopB to the same extent in the membrane-bound and the solubilized state, the gas most likely acts by direct binding to the protein. While this mechanism of inhibition of CopB by xenon requires further verification, xenon-inhibition of an ion-pumping ATPase by xenon per se is novel and has far-reaching ramifications. Eukaryotic cell function depends on the operation of membranous ion pumps, like the Na,K-ATPase, the Ca-ATPase, or copper ATPases. The two human copper ATPases, ATP7A and ATP7B are closely related to CopB and other bacterial copper pumps [47] and are inextricably linked to satisfying systemic and central nervous system requirements for copper [48]. Copper also plays a key role at the synapse and in synaptic transmission and in the past decade, a physiological role for copper in regulating neuronal excitability has emerged [49]. Xenon-inhibition of neuronal copper ATPases would of course have far-reaching consequences on brain function and may contribute or even be central to the anesthetic effects of this noble gas. None of our findings precludes the possibility that in addition to direct action of xenon on proteins, xenon can affect channel and pump functions by membrane-exerted mechanisms caused by xenon accumulation in the lipid bilayer.

Conclusion

Xenon is used as an anesthetic in human medicine and consequently, there is great interest in its molecular mode of action. Since xenon is hydrophobic, it readily partitions into membranes as well as hydrophobic cavities in proteins. Since there are multiple targets for xenon, the mechanism of the anesthetic effects of the gas has been difficult to resolve. It is generally assumed that the anesthetic effect is due to inhibition of one or several gated neuronal channels. As a proof of concept we here show that the spontaneously gating MscL-G22E mutant of the E. coli mechano-sensitive MscL channel is also inhibited by xenon. As a second model system for an integral membrane protein, the CopB copper ATPase of E. hirae was used. Its activity can be assessed both, in a membrane-embedded state and in solution. Xenon inhibits CopB when reconstituted in proteoliposome or when in solution, suggesting that inhibition is governed by direct interaction of the gas with the protein. Since copper ATPases play a pivotal role in brain function, the inhibition of copper pumps by xenon points to a novel possible mode of action of xenon in anesthesia.

Supporting information

S1 File. All Supporting information.

(Figure A) Purification of MscL-G22E. (Figure B) Device for saturation of solution with xenon. (Table A) Protease inhibitors and composition of 100x stock solution. (Figure C) Determination of the xenon concentration in buffers. (Figure D) Purification of CopB. (Figure E) Freeze-fracture electron micrographs of CopB proteoliposomes.

https://doi.org/10.1371/journal.pone.0198110.s001

(PDF)

References

1. Lawrence JH, Loomis WF, Tobias CA, Turpin FH. Preliminary observations on the narcotic effect of xenon with a review of values for solubilities of gases in water and oils. J Physiol. 1946;105: 197–204. Available: http://www.ncbi.nlm.nih.gov/pubmed/16991720
- View Article
- Google Scholar
2. Cullen SC, Gross EG. The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science. 1951;113: 580–2. pmid:14834873
- View Article
- PubMed/NCBI
- Google Scholar
3. Weinrich M, Worcester DL. Xenon and other volatile anesthetics change domain structure in model lipid raft membranes. J Phys Chem B. 2013;117: 16141–7. pmid:24299622
- View Article
- PubMed/NCBI
- Google Scholar
4. Booker RD, Sum AK. Biophysical changes induced by xenon on phospholipid bilayers. Biochim Biophys Acta—Biomembr. 2013;1828: 1347–1356. pmid:23376329
- View Article
- PubMed/NCBI
- Google Scholar
5. Stimson LM, Vattulainen I, Róg T, Karttunen M. Exploring the effect of xenon on biomembranes. Cell Mol Biol Lett. 2005;10: 563–9. Available: isi:000234609300001 pmid:16341267
- View Article
- PubMed/NCBI
- Google Scholar
6. Meyer H. Zur Theorie der Alkoholnarkose. Arch Exp Pathol Pharmakol. 1899;42: 109–118.
- View Article
- Google Scholar
7. Overton E. Studien über die Narkose, zugleich ein Beitrag zur allgemeinen Pharmakologie. Jena: Verlag Gustav Fischer; 1901.
8. Dickinson R, Franks NP. Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection. Crit Care. 2010;14: 229. pmid:20836899
- View Article
- PubMed/NCBI
- Google Scholar
9. Cantor RS. The lateral pressure profile in membranes: A physical mechanism of general anesthesia. Biochemistry. 1997;36: 2339–2344. pmid:9054538
- View Article
- PubMed/NCBI
- Google Scholar
10. Prangé T, Schiltz M, Pernot L, Colloc’h N, Longhi S, Bourguet W, et al. Exploring hydrophobic sites in proteins with xenon or krypton. Proteins. 1998;30: 61–73. Available: http://www.ncbi.nlm.nih.gov/pubmed/9443341 pmid:9443341
- View Article
- PubMed/NCBI
- Google Scholar
11. Luna VM, Chen Y, Fee JA, Stout CD. Crystallographic studies of Xe and Kr binding within the large internal cavity of cytochrome ba3 from Thermus thermophilus: structural analysis and role of oxygen transport channels in the heme-Cu oxidases. Biochemistry. 2008;47: 4657–65. pmid:18376849
- View Article
- PubMed/NCBI
- Google Scholar
12. Salmi E, Laitio RM, Aalto S, Maksimow AT, Långsjö JW, Kaisti KK, et al. Xenon does not affect gamma-aminobutyric acid type A receptor binding in humans. Anesth Analg. 2008;106: 129–34 pmid:18165567
- View Article
- PubMed/NCBI
- Google Scholar
13. Hapfelmeier G, Zieglgänsberger W, Haseneder R, Schneck H, Kochs E. Nitrous oxide and xenon increase the efficacy of GABA at recombinant mammalian GABA(A) receptors. Anesth Analg. 2000;91: 1542–9. Available: http://www.ncbi.nlm.nih.gov/pubmed/11094015 pmid:11094015
- View Article
- PubMed/NCBI
- Google Scholar
14. Franks NP, Dickinson R, de Sousa SL, Hall AC, Lieb WR. How does xenon produce anaesthesia? Nature. 1998;396: 324. pmid:9845069
- View Article
- PubMed/NCBI
- Google Scholar
15. Banks P, Franks NP, Dickinson R. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia. Anesthesiology. 2010;112: 614–22. pmid:20124979
- View Article
- PubMed/NCBI
- Google Scholar
16. Harris K, Armstrong SP, Campos-Pires R, Kiru L, Franks NP, Dickinson R. Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site. Anesthesiology. 2013;119: 1137–48. pmid:23867231
- View Article
- PubMed/NCBI
- Google Scholar
17. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol. 2004;65: 443–452. Available: isi:000188329800021 pmid:14742687
- View Article
- PubMed/NCBI
- Google Scholar
18. Bantel C, Maze M, Trapp S. Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener. Anesthesiology. 2010;112: 623–30. pmid:20179498
- View Article
- PubMed/NCBI
- Google Scholar
19. Li Q, Lian C, Zhou R, Li T, Xiang X, Liu B. Pretreatment with xenon protected immature rabbit heart from ischaemia/reperfusion injury by opening of the mitoKATP channel. Heart Lung Circ. 2013;22: 276–83. pmid:23261327
- View Article
- PubMed/NCBI
- Google Scholar
20. Sauguet L, Fourati Z, Prangé T, Delarue M, Colloc’h N. Structural basis for xenon inhibition in a cationic pentameric ligand-gated ion channel. PLoS One. 2016;11: e0149795. pmid:26910105
- View Article
- PubMed/NCBI
- Google Scholar
21. Markin VS, Martinac B. Mechanosensitive ion channels as reporters of bilayer expansion. A theoretical model. Biophys J. 1991;60: 1120–1127. pmid:1722115
- View Article
- PubMed/NCBI
- Google Scholar
22. Cranfield CG, Kloda A, Nomura T, Petrov E, Battle A, Constantine M, et al. Force from lipids: A multidisciplinary approach to study bacterial mechanosensitive ion channels. In: Kamkin A. and Lozinsky I (Eds.) Mechanically Gated Channels and their Regulation. Dordrecht: Springer Netherlands; 2012. pp. 1–33. https://doi.org/10.1007/978-94-007-5073-9_1
23. Petrov E, Martinac B. Modulation of channel activity and gadolinium block of MscL by static magnetic fields. Eur Biophys J. 2007;36: 95–105. pmid:17089151
- View Article
- PubMed/NCBI
- Google Scholar
24. Perozo E, Kloda A, Cortes DM, Martinac B. Physical principles underlying the transduction of bilayer deformation forces during mechanosensitive channel gating. Nat Struct Biol. 2002;9: 696–703. Available: isi:000177656200016 pmid:12172537
- View Article
- PubMed/NCBI
- Google Scholar
25. Powl AM, East JM, Lee AG. Anionic phospholipids affect the rate and extent of flux through the mechanosensitive channel of large conductance MscL. Biochemistry. 2008;47: 4317–4328. pmid:18341289
- View Article
- PubMed/NCBI
- Google Scholar
26. Nomura T, Cranfield CG, Deplazes E, Owen DM, Macmillan A, Battle AR, et al. Differential effects of lipids and lyso-lipids on the mechanosensitivity of the mechanosensitive channels MscL and MscS. Proc Natl Acad Sci U S A. 2012;109: 8770–8775. Available: isi:000304881700081 pmid:22586095
- View Article
- PubMed/NCBI
- Google Scholar
27. Mukherjee N, Jose MD, Birkner JP, Walko M, Ingolfsson HI, Dimitrova A, et al. The activation mode of the mechanosensitive ion channel, MscL, by lysophosphatidylcholine differs from tension-induced gating. Faseb J. 2014;28: 4292–4302. Available: isi:000342222700009 pmid:24958207
- View Article
- PubMed/NCBI
- Google Scholar
28. Laganowsky A, Reading E, Allison TM, Ulmschneider MB, Degiacomi MT, Baldwin AJ, et al. Membrane proteins bind lipids selectively to modulate their structure and function. Nature. 2014;510: 172–5. pmid:24899312
- View Article
- PubMed/NCBI
- Google Scholar
29. Chang G, Spencer RH, Lee AT, Barclay MT, Rees DC. Structure of the MscL homolog from Mycobacterium tuberculosis: A gated mechanosensitive ion channel. Science. 1998;282: 2220–2226. pmid:9856938
- View Article
- PubMed/NCBI
- Google Scholar
30. Solioz M, Stoyanov J V. Copper homeostasis in Enterococcus hirae. FEMS Microbiol Rev. 2003;27: 183–195. pmid:12829267
- View Article
- PubMed/NCBI
- Google Scholar
31. Bissig KD, Wunderli-Ye H, Duda P, Solioz M. Structure-function analysis of purified Enterococcus hirae CopB copper ATPase: effect of Menkes/Wilson disease mutation homologues. Biochem J. 2001;357: 217. pmid:11415452
- View Article
- PubMed/NCBI
- Google Scholar
32. Häse CC, Le Dain AC, Martinac B. Purification and functional reconstitution of the recombinant large mechanosensitive ion channel (MscL) of Escherichia coli. J Biol Chem. 1995;270: 18329–34. Available: http://www.ncbi.nlm.nih.gov/pubmed/7543101 pmid:7543101
- View Article
- PubMed/NCBI
- Google Scholar
33. Apponyi MA, Ozawa K, Dixon NE, Otting G. Cell-free protein synthesis for analysis by NMR spectroscopy. Methods Mol Biol. 2008;426: 257–68. pmid:18542869
- View Article
- PubMed/NCBI
- Google Scholar
34. Delcour AH, Martinac B, Adler J, Kung C. Modified reconstitution method used in patch-clamp studies of Escherichia coli ion channels. Biophys J. 1989;56: 631–636. pmid:2477074
- View Article
- PubMed/NCBI
- Google Scholar
35. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch—Eur J Physiol. 1981;391: 85–100.
- View Article
- Google Scholar
36. Macdonald AG, Martinac B. Effect of high hydrostatic pressure on the porin OmpC from Escherichia coli. FEMS Microbiol Lett. 1999;173: 327–334. Available: isi:000079640800008 pmid:10227163
- View Article
- PubMed/NCBI
- Google Scholar
37. Petrov E., Rohde P.R. & Martinac B. (2011) “Flying-patch” patch-clamp study of G22E MscL mutant under high hydrostatic pressure. Biophys J. 100: 1635–1641. pmid:21463576
- View Article
- PubMed/NCBI
- Google Scholar
38. Odermatt A, Solioz M. Two trans-acting metalloregulatory proteins controlling expression of the copper-ATPases of Enterococcus hirae. J Biol Chem. 1995;270: 4349–54. Available: http://www.ncbi.nlm.nih.gov/pubmed/7876197 pmid:7876197
- View Article
- PubMed/NCBI
- Google Scholar
39. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72: 248–254. pmid:942051
- View Article
- PubMed/NCBI
- Google Scholar
40. Laemmli UK, Favre M. Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol. 1973;80: 575–99. Available: http://www.ncbi.nlm.nih.gov/pubmed/4204102 pmid:4204102
- View Article
- PubMed/NCBI
- Google Scholar
41. Lanzetta PA, Alvarez LJ, Reinach PS, Candia OA. An improved assay for nanomole amounts of inorganic phosphate. Anal Biochem. 1979;100: 95–97. pmid:161695
- View Article
- PubMed/NCBI
- Google Scholar
42. Yoshimura K, Batiza A, Schroeder M, Blount P, Kung C. Hydrophilicity of a single residue within MscL correlates with increased channel mechanosensitivity. Biophys J. 1999;77: 1960–1972. Available: isi:000083059800016 pmid:10512816
- View Article
- PubMed/NCBI
- Google Scholar
43. Wyler-Duda P, Solioz M. Phosphoenzyme formation by purified, reconstituted copper ATPase of Enterococcus hirae. FEBS Lett. 1996;399: 143–6. Available: http://www.ncbi.nlm.nih.gov/pubmed/8980139 pmid:8980139
- View Article
- PubMed/NCBI
- Google Scholar
44. Perozo E, Cortes DM, Sompornpisut P, Kloda A, Martinac B. Open channel structure of MscL and the gating mechanism of mechanosensitive channels. Nature. 2002;418: 942–948. pmid:12198539
- View Article
- PubMed/NCBI
- Google Scholar
45. Graesbøll K, Sasse-Middelhoff H, Heimburg T. The thermodynamics of general and local anesthesia. Biophys J. 2014;106: 2143–56. pmid:24853743
- View Article
- PubMed/NCBI
- Google Scholar
46. Bissig KD, Voegelin TC, Solioz M. Tetrathiomolybdate inhibition of the Enterococcus hirae CopB copper ATPase. FEBS Lett. 2001;507: 367–70. Available: http://www.ncbi.nlm.nih.gov/pubmed/11696373 pmid:11696373
- View Article
- PubMed/NCBI
- Google Scholar
47. Solioz M, Vulpe C. CPx-type ATPases: a class of P-type ATPases that pump heavy metals. Trends Biochem Sci. 1996;21: 237–41. Available: http://www.ncbi.nlm.nih.gov/pubmed/8755241 pmid:8755241
- View Article
- PubMed/NCBI
- Google Scholar
48. Telianidis J, Hung YH, Materia S, La Fontaine S. Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis. Front Aging Neurosci. 2013;5: 44. pmid:23986700
- View Article
- PubMed/NCBI
- Google Scholar
49. La Fontaine S. New insights into CNS requirements for the copper-ATPase, ATP7A. Focus on “Autonomous requirements of the Menkes disease protein in the nervous system”. Am J Physiol Cell Physiol. 2015;309: C719–21. pmid:26468209
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Lawrence JH, Loomis WF, Tobias CA, Turpin FH. Preliminary observations on the narcotic effect of xenon with a review of values for solubilities of gases in water and oils. J Physiol. 1946;105: 197–204. Available: http://www.ncbi.nlm.nih.gov/pubmed/16991720
View Article
Google Scholar

[2] View Article

[3] Google Scholar

[ref2] 2. Cullen SC, Gross EG. The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science. 1951;113: 580–2. pmid:14834873
View Article
PubMed/NCBI
Google Scholar

[5] View Article

[6] PubMed/NCBI

[7] Google Scholar

[ref3] 3. Weinrich M, Worcester DL. Xenon and other volatile anesthetics change domain structure in model lipid raft membranes. J Phys Chem B. 2013;117: 16141–7. pmid:24299622
View Article
PubMed/NCBI
Google Scholar

[9] View Article

[10] PubMed/NCBI

[11] Google Scholar

[ref4] 4. Booker RD, Sum AK. Biophysical changes induced by xenon on phospholipid bilayers. Biochim Biophys Acta—Biomembr. 2013;1828: 1347–1356. pmid:23376329
View Article
PubMed/NCBI
Google Scholar

[13] View Article

[14] PubMed/NCBI

[15] Google Scholar

[ref5] 5. Stimson LM, Vattulainen I, Róg T, Karttunen M. Exploring the effect of xenon on biomembranes. Cell Mol Biol Lett. 2005;10: 563–9. Available: isi:000234609300001 pmid:16341267
View Article
PubMed/NCBI
Google Scholar

[17] View Article

[18] PubMed/NCBI

[19] Google Scholar

[ref6] 6. Meyer H. Zur Theorie der Alkoholnarkose. Arch Exp Pathol Pharmakol. 1899;42: 109–118.
View Article
Google Scholar

[21] View Article

[22] Google Scholar

[ref7] 7. Overton E. Studien über die Narkose, zugleich ein Beitrag zur allgemeinen Pharmakologie. Jena: Verlag Gustav Fischer; 1901.

[ref8] 8. Dickinson R, Franks NP. Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection. Crit Care. 2010;14: 229. pmid:20836899
View Article
PubMed/NCBI
Google Scholar

[25] View Article

[26] PubMed/NCBI

[27] Google Scholar

[ref9] 9. Cantor RS. The lateral pressure profile in membranes: A physical mechanism of general anesthesia. Biochemistry. 1997;36: 2339–2344. pmid:9054538
View Article
PubMed/NCBI
Google Scholar

[29] View Article

[30] PubMed/NCBI

[31] Google Scholar

[ref10] 10. Prangé T, Schiltz M, Pernot L, Colloc’h N, Longhi S, Bourguet W, et al. Exploring hydrophobic sites in proteins with xenon or krypton. Proteins. 1998;30: 61–73. Available: http://www.ncbi.nlm.nih.gov/pubmed/9443341 pmid:9443341
View Article
PubMed/NCBI
Google Scholar

[33] View Article

[34] PubMed/NCBI

[35] Google Scholar

[ref11] 11. Luna VM, Chen Y, Fee JA, Stout CD. Crystallographic studies of Xe and Kr binding within the large internal cavity of cytochrome ba3 from Thermus thermophilus: structural analysis and role of oxygen transport channels in the heme-Cu oxidases. Biochemistry. 2008;47: 4657–65. pmid:18376849
View Article
PubMed/NCBI
Google Scholar

[37] View Article

[38] PubMed/NCBI

[39] Google Scholar

[ref12] 12. Salmi E, Laitio RM, Aalto S, Maksimow AT, Långsjö JW, Kaisti KK, et al. Xenon does not affect gamma-aminobutyric acid type A receptor binding in humans. Anesth Analg. 2008;106: 129–34 pmid:18165567
View Article
PubMed/NCBI
Google Scholar

[41] View Article

[42] PubMed/NCBI

[43] Google Scholar

[ref13] 13. Hapfelmeier G, Zieglgänsberger W, Haseneder R, Schneck H, Kochs E. Nitrous oxide and xenon increase the efficacy of GABA at recombinant mammalian GABA(A) receptors. Anesth Analg. 2000;91: 1542–9. Available: http://www.ncbi.nlm.nih.gov/pubmed/11094015 pmid:11094015
View Article
PubMed/NCBI
Google Scholar

[45] View Article

[46] PubMed/NCBI

[47] Google Scholar

[ref14] 14. Franks NP, Dickinson R, de Sousa SL, Hall AC, Lieb WR. How does xenon produce anaesthesia? Nature. 1998;396: 324. pmid:9845069
View Article
PubMed/NCBI
Google Scholar

[49] View Article

[50] PubMed/NCBI

[51] Google Scholar

[ref15] 15. Banks P, Franks NP, Dickinson R. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia. Anesthesiology. 2010;112: 614–22. pmid:20124979
View Article
PubMed/NCBI
Google Scholar

[53] View Article

[54] PubMed/NCBI

[55] Google Scholar

[ref16] 16. Harris K, Armstrong SP, Campos-Pires R, Kiru L, Franks NP, Dickinson R. Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site. Anesthesiology. 2013;119: 1137–48. pmid:23867231
View Article
PubMed/NCBI
Google Scholar

[57] View Article

[58] PubMed/NCBI

[59] Google Scholar

[ref17] 17. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol. 2004;65: 443–452. Available: isi:000188329800021 pmid:14742687
View Article
PubMed/NCBI
Google Scholar

[61] View Article

[62] PubMed/NCBI

[63] Google Scholar

[ref18] 18. Bantel C, Maze M, Trapp S. Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener. Anesthesiology. 2010;112: 623–30. pmid:20179498
View Article
PubMed/NCBI
Google Scholar

[65] View Article

[66] PubMed/NCBI

[67] Google Scholar

[ref19] 19. Li Q, Lian C, Zhou R, Li T, Xiang X, Liu B. Pretreatment with xenon protected immature rabbit heart from ischaemia/reperfusion injury by opening of the mitoKATP channel. Heart Lung Circ. 2013;22: 276–83. pmid:23261327
View Article
PubMed/NCBI
Google Scholar

[69] View Article

[70] PubMed/NCBI

[71] Google Scholar

[ref20] 20. Sauguet L, Fourati Z, Prangé T, Delarue M, Colloc’h N. Structural basis for xenon inhibition in a cationic pentameric ligand-gated ion channel. PLoS One. 2016;11: e0149795. pmid:26910105
View Article
PubMed/NCBI
Google Scholar

[73] View Article

[74] PubMed/NCBI

[75] Google Scholar

[ref21] 21. Markin VS, Martinac B. Mechanosensitive ion channels as reporters of bilayer expansion. A theoretical model. Biophys J. 1991;60: 1120–1127. pmid:1722115
View Article
PubMed/NCBI
Google Scholar

[77] View Article

[78] PubMed/NCBI

[79] Google Scholar

[ref22] 22. Cranfield CG, Kloda A, Nomura T, Petrov E, Battle A, Constantine M, et al. Force from lipids: A multidisciplinary approach to study bacterial mechanosensitive ion channels. In: Kamkin A. and Lozinsky I (Eds.) Mechanically Gated Channels and their Regulation. Dordrecht: Springer Netherlands; 2012. pp. 1–33. https://doi.org/10.1007/978-94-007-5073-9_1

[ref23] 23. Petrov E, Martinac B. Modulation of channel activity and gadolinium block of MscL by static magnetic fields. Eur Biophys J. 2007;36: 95–105. pmid:17089151
View Article
PubMed/NCBI
Google Scholar

[82] View Article

[83] PubMed/NCBI

[84] Google Scholar

[ref24] 24. Perozo E, Kloda A, Cortes DM, Martinac B. Physical principles underlying the transduction of bilayer deformation forces during mechanosensitive channel gating. Nat Struct Biol. 2002;9: 696–703. Available: isi:000177656200016 pmid:12172537
View Article
PubMed/NCBI
Google Scholar

[86] View Article

[87] PubMed/NCBI

[88] Google Scholar

[ref25] 25. Powl AM, East JM, Lee AG. Anionic phospholipids affect the rate and extent of flux through the mechanosensitive channel of large conductance MscL. Biochemistry. 2008;47: 4317–4328. pmid:18341289
View Article
PubMed/NCBI
Google Scholar

[90] View Article

[91] PubMed/NCBI

[92] Google Scholar

[ref26] 26. Nomura T, Cranfield CG, Deplazes E, Owen DM, Macmillan A, Battle AR, et al. Differential effects of lipids and lyso-lipids on the mechanosensitivity of the mechanosensitive channels MscL and MscS. Proc Natl Acad Sci U S A. 2012;109: 8770–8775. Available: isi:000304881700081 pmid:22586095
View Article
PubMed/NCBI
Google Scholar

[94] View Article

[95] PubMed/NCBI

[96] Google Scholar

[ref27] 27. Mukherjee N, Jose MD, Birkner JP, Walko M, Ingolfsson HI, Dimitrova A, et al. The activation mode of the mechanosensitive ion channel, MscL, by lysophosphatidylcholine differs from tension-induced gating. Faseb J. 2014;28: 4292–4302. Available: isi:000342222700009 pmid:24958207
View Article
PubMed/NCBI
Google Scholar

[98] View Article

[99] PubMed/NCBI

[100] Google Scholar

[ref28] 28. Laganowsky A, Reading E, Allison TM, Ulmschneider MB, Degiacomi MT, Baldwin AJ, et al. Membrane proteins bind lipids selectively to modulate their structure and function. Nature. 2014;510: 172–5. pmid:24899312
View Article
PubMed/NCBI
Google Scholar

[102] View Article

[103] PubMed/NCBI

[104] Google Scholar

[ref29] 29. Chang G, Spencer RH, Lee AT, Barclay MT, Rees DC. Structure of the MscL homolog from Mycobacterium tuberculosis: A gated mechanosensitive ion channel. Science. 1998;282: 2220–2226. pmid:9856938
View Article
PubMed/NCBI
Google Scholar

[106] View Article

[107] PubMed/NCBI

[108] Google Scholar

[ref30] 30. Solioz M, Stoyanov J V. Copper homeostasis in Enterococcus hirae. FEMS Microbiol Rev. 2003;27: 183–195. pmid:12829267
View Article
PubMed/NCBI
Google Scholar

[110] View Article

[111] PubMed/NCBI

[112] Google Scholar

[ref31] 31. Bissig KD, Wunderli-Ye H, Duda P, Solioz M. Structure-function analysis of purified Enterococcus hirae CopB copper ATPase: effect of Menkes/Wilson disease mutation homologues. Biochem J. 2001;357: 217. pmid:11415452
View Article
PubMed/NCBI
Google Scholar

[114] View Article

[115] PubMed/NCBI

[116] Google Scholar

[ref32] 32. Häse CC, Le Dain AC, Martinac B. Purification and functional reconstitution of the recombinant large mechanosensitive ion channel (MscL) of Escherichia coli. J Biol Chem. 1995;270: 18329–34. Available: http://www.ncbi.nlm.nih.gov/pubmed/7543101 pmid:7543101
View Article
PubMed/NCBI
Google Scholar

[118] View Article

[119] PubMed/NCBI

[120] Google Scholar

[ref33] 33. Apponyi MA, Ozawa K, Dixon NE, Otting G. Cell-free protein synthesis for analysis by NMR spectroscopy. Methods Mol Biol. 2008;426: 257–68. pmid:18542869
View Article
PubMed/NCBI
Google Scholar

[122] View Article

[123] PubMed/NCBI

[124] Google Scholar

[ref34] 34. Delcour AH, Martinac B, Adler J, Kung C. Modified reconstitution method used in patch-clamp studies of Escherichia coli ion channels. Biophys J. 1989;56: 631–636. pmid:2477074
View Article
PubMed/NCBI
Google Scholar

[126] View Article

[127] PubMed/NCBI

[128] Google Scholar

[ref35] 35. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch—Eur J Physiol. 1981;391: 85–100.
View Article
Google Scholar

[130] View Article

[131] Google Scholar

[ref36] 36. Macdonald AG, Martinac B. Effect of high hydrostatic pressure on the porin OmpC from Escherichia coli. FEMS Microbiol Lett. 1999;173: 327–334. Available: isi:000079640800008 pmid:10227163
View Article
PubMed/NCBI
Google Scholar

[133] View Article

[134] PubMed/NCBI

[135] Google Scholar

[ref37] 37. Petrov E., Rohde P.R. & Martinac B. (2011) “Flying-patch” patch-clamp study of G22E MscL mutant under high hydrostatic pressure. Biophys J. 100: 1635–1641. pmid:21463576
View Article
PubMed/NCBI
Google Scholar

[137] View Article

[138] PubMed/NCBI

[139] Google Scholar

[ref38] 38. Odermatt A, Solioz M. Two trans-acting metalloregulatory proteins controlling expression of the copper-ATPases of Enterococcus hirae. J Biol Chem. 1995;270: 4349–54. Available: http://www.ncbi.nlm.nih.gov/pubmed/7876197 pmid:7876197
View Article
PubMed/NCBI
Google Scholar

[141] View Article

[142] PubMed/NCBI

[143] Google Scholar

[ref39] 39. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72: 248–254. pmid:942051
View Article
PubMed/NCBI
Google Scholar

[145] View Article

[146] PubMed/NCBI

[147] Google Scholar

[ref40] 40. Laemmli UK, Favre M. Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol. 1973;80: 575–99. Available: http://www.ncbi.nlm.nih.gov/pubmed/4204102 pmid:4204102
View Article
PubMed/NCBI
Google Scholar

[149] View Article

[150] PubMed/NCBI

[151] Google Scholar

[ref41] 41. Lanzetta PA, Alvarez LJ, Reinach PS, Candia OA. An improved assay for nanomole amounts of inorganic phosphate. Anal Biochem. 1979;100: 95–97. pmid:161695
View Article
PubMed/NCBI
Google Scholar

[153] View Article

[154] PubMed/NCBI

[155] Google Scholar

[ref42] 42. Yoshimura K, Batiza A, Schroeder M, Blount P, Kung C. Hydrophilicity of a single residue within MscL correlates with increased channel mechanosensitivity. Biophys J. 1999;77: 1960–1972. Available: isi:000083059800016 pmid:10512816
View Article
PubMed/NCBI
Google Scholar

[157] View Article

[158] PubMed/NCBI

[159] Google Scholar

[ref43] 43. Wyler-Duda P, Solioz M. Phosphoenzyme formation by purified, reconstituted copper ATPase of Enterococcus hirae. FEBS Lett. 1996;399: 143–6. Available: http://www.ncbi.nlm.nih.gov/pubmed/8980139 pmid:8980139
View Article
PubMed/NCBI
Google Scholar

[161] View Article

[162] PubMed/NCBI

[163] Google Scholar

[ref44] 44. Perozo E, Cortes DM, Sompornpisut P, Kloda A, Martinac B. Open channel structure of MscL and the gating mechanism of mechanosensitive channels. Nature. 2002;418: 942–948. pmid:12198539
View Article
PubMed/NCBI
Google Scholar

[165] View Article

[166] PubMed/NCBI

[167] Google Scholar

[ref45] 45. Graesbøll K, Sasse-Middelhoff H, Heimburg T. The thermodynamics of general and local anesthesia. Biophys J. 2014;106: 2143–56. pmid:24853743
View Article
PubMed/NCBI
Google Scholar

[169] View Article

[170] PubMed/NCBI

[171] Google Scholar

[ref46] 46. Bissig KD, Voegelin TC, Solioz M. Tetrathiomolybdate inhibition of the Enterococcus hirae CopB copper ATPase. FEBS Lett. 2001;507: 367–70. Available: http://www.ncbi.nlm.nih.gov/pubmed/11696373 pmid:11696373
View Article
PubMed/NCBI
Google Scholar

[173] View Article

[174] PubMed/NCBI

[175] Google Scholar

[ref47] 47. Solioz M, Vulpe C. CPx-type ATPases: a class of P-type ATPases that pump heavy metals. Trends Biochem Sci. 1996;21: 237–41. Available: http://www.ncbi.nlm.nih.gov/pubmed/8755241 pmid:8755241
View Article
PubMed/NCBI
Google Scholar

[177] View Article

[178] PubMed/NCBI

[179] Google Scholar

[ref48] 48. Telianidis J, Hung YH, Materia S, La Fontaine S. Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis. Front Aging Neurosci. 2013;5: 44. pmid:23986700
View Article
PubMed/NCBI
Google Scholar

[181] View Article

[182] PubMed/NCBI

[183] Google Scholar

[ref49] 49. La Fontaine S. New insights into CNS requirements for the copper-ATPase, ATP7A. Focus on “Autonomous requirements of the Menkes disease protein in the nervous system”. Am J Physiol Cell Physiol. 2015;309: C719–21. pmid:26468209
View Article
PubMed/NCBI
Google Scholar

[185] View Article

[186] PubMed/NCBI

[187] Google Scholar

Figures

Abstract

Introduction

Materials and methods

Cell-free expression construct and MscL-G22E

Liposome reconstitution of MscL-G22E

Patch clamp and “flying-patch” electrophysiology of MscL-G22E

Measurements with xenon

CopB ATPase purification

Reconstitution of CopB

ATPase assays

Results

Effect of xenon on MscL-G22E

Effects of xenon on solubilized CopB

Effects of xenon on reconstituted CopB

Discussion

Conclusion

Supporting information

S1 File. All Supporting information.

References